Reaction

Abdominal Infection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,513 reports · 85 co-occurring drugs

As of the last recalculation, Abdominal Infection appears in 2,513 FAERS reports alongside 85 co-occurring drug terms. The strongest observed disproportionality signal is GANCICLOVIR SODIUM (PRR 15.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Ganciclovir Sodium	19	15.0	15.0
Basiliximab	21	14.9	14.9
Ganciclovir	18	14.7	14.7
Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride And Dextrose	11	11.2	11.2
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	40	10.8	10.8
Human Immunoglobulin G	22	8.9	8.9
Amphotericin B	13	8.6	8.6
Piperacillin Sodium And Tazobactam Sodium	19	8.1	8.1
Tacrolimus Ointment 0.1%	116	8.0	8.0
Tacrolimus Extended-Release Capsules	116	8.0	8.0
Leucovorin Calcium	18	7.8	7.9
Irinotecan Hydrochloride	12	7.8	7.8
Dextrose Monohydrate	12	7.5	7.5
Meperidine Hydrochloride	8	7.2	7.2
Octreotide Acetate	26	7.1	7.1
Tacrolimus	128	7.1	7.1
Oxaliplatin	62	7.1	7.1
Dextrose	11	6.9	6.9
Mycophenolate Mofetil	108	6.8	6.8
Mycophenolate Mofetil Hydrochloride	108	6.8	6.8
Pegaspargase	10	6.8	6.8
Teduglutide	11	6.8	6.8
Rifaximin	17	6.8	6.8
Diphenoxylate Hydrochloride And Atropine Sulfate	11	6.7	6.7
Gemcitabine Hydrochloride	42	6.7	6.7
Gemcitabine	31	6.6	6.6
Brentuximab Vedotin	8	6.5	6.5
Prochlorperazine Maleate	7	6.3	6.3
Voriconazole Injection	16	6.1	6.1
Cladribine	7	6.0	6.1
Mycophenilic Acid	15	6.0	6.0
Loperamide Hcl	9	5.8	5.8
Fluorouracil	53	5.8	5.8
Fluorouracil Cream, 0.5%	52	5.7	5.7
Loperamide Hydrochloride Oral	7	5.7	5.7
Granisetron Hydrochloride	7	5.6	5.6
Meropenem	21	5.5	5.5
Daptomycin	6	5.4	5.4
Bevacizumab	78	5.4	5.4
Cytarabine	38	5.3	5.3
Vancomycin	36	5.2	5.2
Piperacillin And Tazobactam	8	5.2	5.2
Anti-Thymocyte Globulin (Rabbit)	5	5.1	5.1
Vancomycin Hydrochloride	40	5.1	5.1
Entecavir	7	5.0	5.0
Sirolimus	8	4.9	4.9
Tobramycin Solution	7	4.8	4.8
Piperacillin Sodium,Tazobactam Sodium	15	4.7	4.7
Tobramycin Sulfate	7	4.7	4.7
Voriconazole	17	4.7	4.7
Docetaxel Anhydrous	37	4.6	4.6
Docetaxel	37	4.6	4.6
Azacitidine For	10	4.6	4.6
Atezolizumab	21	4.5	4.5
Imatinib	9	4.2	4.2
Linezolid	15	4.2	4.2
Paclitaxel	49	4.2	4.2
Durvalumab	10	4.1	4.1
Granisetron	5	4.0	4.0
Azacitidine	14	3.9	3.9
Micafungin Sodium	4	3.9	3.9
Trifluridine And Tipiracil	5	3.9	3.9
Ustekinumab	47	3.9	3.9
Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride	4	3.7	3.8
Bendamustine Hcl	7	3.7	3.7
Panitumumab	7	3.7	3.7
Regorafenib	5	3.6	3.6
Obinutuzumab	7	3.5	3.5
Paclitaxel (Aibumin-Bound)	34	3.5	3.5
Baricitinib	4	3.4	3.4
Vedolizumab	34	3.3	3.3
Blinatumomab	4	3.2	3.2
Lanreotide Acetate	3	3.2	3.2
Cetuximab	11	2.9	2.9
Selinexor	3	2.9	2.9
Vismodegib	3	2.8	2.8
Lenvatinib	11	2.8	2.8
Ofatumumab	10	2.5	2.5
Olaparib	6	2.4	2.4
Sevelamer Carbonate	3	2.2	2.2
Axitinib	5	2.1	2.1
Tafamidis	3	2.1	2.1
Elexacaftor, Tezacaftor, And Ivacaftor	3	2.0	2.0
Palivizumab	3	1.6	1.6
Levonorgestrel	24	1.0	1.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.